Representatives from Japan and Korea, along with professional DCT organizations, share real-world implementation experiences, offering insights into how international teams overcome regional, institutional, and technological challenges to advance decentralized clinical trials.

Focusing on the perspectives of regulatory agencies and Institutional Review Boards (IRBs), this session discusses how to expand the possibilities of DCT within existing legal frameworks, establishing a trustworthy foundation of ethics and compliance.

Exploring the potential applications and cybersecurity challenges of digital devices in DCTs, this session provides a comprehensive discussion from technology to trust, facilitating the true digital transformation of clinical research.

Practical speakers share experiences in hospital implementation, the role of pharmaceutical companies, and collaborative logistics processes, presenting DCT as "not just technology, but a comprehensive system"